Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
Journal for Immunotherapy of Cancer
|
October 18, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0
Anna C Pavlick, Charlotte E Ariyan, Elizabeth I Buchbinder, et al.
Oncoimmunology
|
December 15, 2018
Clinical characterization of colitis arising from anti-PD-1 based therapy
Daniel Y Wang, Meghan J Mooradian, DaeWon Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 8, 2014
Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor
Douglas B Johnson, Keith T Flaherty, Jeffrey S Weber, et al.
Lancet (London, England)
|
January 21, 2024
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
Jeffrey S Weber, Matteo S Carlino, Adnan Khattak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2022
First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response
Timothy A Yap, Justin F Gainor, Margaret K Callahan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2021
The State of Melanoma: Emergent Challenges and Opportunities
Michael B Atkins, Clara Curiel-Lewandrowski, David E Fisher, et al.
The British Journal of Dermatology
|
October 22, 2024
Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma
Erin McGillivray, Karam Ashouri, Eftychia Chatziioannou, et al.
The New England Journal of Medicine
|
March 1, 2023
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
Sapna P Patel, Megan Othus, Yuanbin Chen, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
Journal for Immunotherapy of Cancer
|
October 18, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0
Anna C Pavlick, Charlotte E Ariyan, Elizabeth I Buchbinder, et al.
Oncoimmunology
|
December 15, 2018
Clinical characterization of colitis arising from anti-PD-1 based therapy
Daniel Y Wang, Meghan J Mooradian, DaeWon Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 8, 2014
Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor
Douglas B Johnson, Keith T Flaherty, Jeffrey S Weber, et al.
Lancet (London, England)
|
January 21, 2024
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
Jeffrey S Weber, Matteo S Carlino, Adnan Khattak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2022
First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response
Timothy A Yap, Justin F Gainor, Margaret K Callahan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2021
The State of Melanoma: Emergent Challenges and Opportunities
Michael B Atkins, Clara Curiel-Lewandrowski, David E Fisher, et al.
The British Journal of Dermatology
|
October 22, 2024
Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma
Erin McGillivray, Karam Ashouri, Eftychia Chatziioannou, et al.
The New England Journal of Medicine
|
March 1, 2023
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
Sapna P Patel, Megan Othus, Yuanbin Chen, et al.
Page
of 6